NASH Management in 2022: benefits of lifestyle recommendations, including nutrition and exercise

Prof. Stephen Harrison (USA) discusses state of the art management of non-alcoholic steatohepatitis (NASH) in 2022. He focuses on the benefits of lifestyle recommendations, including nutrition and exercise. He shows that weight loss is associated with NASH resolution and fibrosis regression over time following bariatric surgery in patients with severe obesity and NASH.
Play Video

Prof. Stephen Harrison (USA) mentions that NASH progression to clinical outcomes may take time, hence trials for NASH treatment look at surrogate outcomes (histologic endpoints) which are NASH resolution and/or fibrosis improvement approved by the FDA. Further he explores if NASH is reversible and also looks into the potential targets for NASH treatment.

Prof. Stephen Harrison

Prof. Stephen Harrison

With over 20 years in the industry, Dr. Harrison has formed a multitude of global and local relationships with like-minded physicians and experts to raise awareness of liver disease and find a treatment for the patients that need it most.

SUBSCRIBE & FOLLOW US

Subscribe Our Newsletter To Get the Lastest Updates